Background/Aims: Influenza vaccination is the most effective method for preventing influenza infection and its complications. The risk groups are children with chronic kidney diseases (CKDs) such as children on peritoneal dialysis (PD) and hemodialysis (HD), predialysis CKD (pCKD) and renal transplant (RTx) patients and immunosuppressed children. The aim of the present study was to assess the safety and immunogenicity of a single administration of a monovalent inactivated pandemic (H1N1) 2009 vaccine in children with CKD. Methods: Patients were given a single intramuscular injection of 0.5 ml of monovalent inactivated vaccine. Results: Totally, there were 25 pediatric patients with a diagnosis of CKD (16 PD, 2 HD, 3 pCKD and 4 RTx). Seroconversion was observed in 15 of the 16 patients with PD. Seroconversion occurred in all patients undergoing pCKD and HD. However, 3 of the RTx patients were seronegative. Conclusion: This study demonstrated a high level of immunogenicity and safety of an (H1N1) 2009 influenza vaccine in children with CKD.

Keywords:
Child, Chronic kidney diseases, Dialysis, Influenza, Renal transplantation
1.
Centers for Disease Control and Prevention (CDC): Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. MMWR Morb Mortal Wkly Rep 2009;58:941-947.
2.
Glezen WP: Emerging infections: pandemic influenza. Epidemiol Rev 1996;18:64-76.
3.
Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, Bresee JS, Cox NJ; Centers for Disease Control and Prevention: Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009;58:1-52.
4.
Printza N, Farmaki E, Bosdou J, Gkoqka C, Papachristou F: Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions. Hum Vaccin 2010;6:819-822.
5.
Marcelli D, Marelli C, Richards N: Influenza A (H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant 2009;24:3566-3572.
6.
Johnson DW, Fleming SJ: The use of vaccines in renal failure. Clin Pharmacokinet 1992;22:434-446.
7.
Temiz G, Kasifoglu N, Kiris A, Ozturk S, Sahin G, Yalcin AU, Us T: Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients. Ren Fail 2010;32:716-720.
8.
Beaudreuil S, Krivine A, Hebibi H, Ducot B, Mazet AA, Taouffik Y, Seidowsky A, Jacquet A, Lorenzo HK, Charpentier B, Francois H, Durrbach A: Efficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patients. Hum Vaccin 2011;7:868-873.
9.
Labriola L, Hombrouck A, Maréchal C, Van Gucht S, Brochier B, Thomas I, Jadoul M, Goubau P: Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients. Nephrol Dial Transplant 2011;26:1424-1428.
10.
Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL: Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009;17:2405-2413.
11.
Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, Stephenson I: Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009;17:2424-2435.
12.
Song JY, Cheong HJ, Ha SH, Kee SY, Jeong HW, Kim WJ: Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination. Am J Nephrol 2006;26:206-211.
13.
Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ: H1N1 vaccination in pediatric renal transplant patients. Transplant Proc 2011;43:1244-1246.
14.
Manuel O, Pascual M, Hoschler K, Giulieri S, Alves D, Ellefsen K, Bart PA, Venetz JP, Calandra T, Cavassini M: Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 2011;52:248-256.
15.
Crespo M, Collado S, Mir M, Cao H, Barbosa F, Serra C, Hidalgo C, Faura A, Montero M, García de Lomas J, Horcajada JP, Puig JM, Pascual J: Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol 2011;6:2208-2214.
16.
Salles MJ, Sens YA, Boas LS, Machado CM: Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 2010;24:E17-E23.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.